Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Interleukin-2 × 90 days × Clear all

Sponsor

Conditions

Melanoma 8 Leukemia, Myeloid, Acute 5 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Select Advanced Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 38 Rituximab 35 Prednisone 22 Doxorubicin 21 fludarabine 15 Vincristine 15 Specimen Handling 14 Oxaliplatin 14 Magnetic Resonance Spectroscopy 14 Lenalidomide 14 Gemcitabine 14 polatuzumab vedotin 13 CT-P10 11 Etoposide 10 Biopsy 9 fludarabine phosphate 7 deltacortene 7 axicabtagene ciloleucel 7 Leukapheresis 7 Immunotherapy, Adoptive 7 venetoclax 6 prednylidene 6 glofitamab 6 pembrolizumab 5 obinutuzumab 5 ibrutinib 5 acalabrutinib 5 Prednisolone 5 tisagenlecleucel 4 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡